MetLife Inc (MET) Stock Forecast
US · Financial Services
Current price
$84.63
Market cap
$54.45B
Mean price target
$92.25
Implied upside
9.0%
Key takeaways
- Analysts rate MetLife Inc a “Buy”, with a mean price target of $92.25 — about 9.0% upside from the current $84.63, based on 16 analysts.
- MET is trading in the middle of its 52-week range, at 78% of the $67.33–$89.62 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 16 |
| Mean target | $92.25 |
| High target | $106.00 |
| Low target | $75.00 |
| Rating split (SB / B / H / S / SS) | 4 / 8 / 6 / 0 / 0 |
Price & trading
| Current price | $84.63 |
|---|---|
| Previous close | $84.60 |
| 52-week high | $89.62 |
| 52-week low | $67.33 |
| 50-day average | $81.53 |
| Beta | 0.78 |
See the full MET breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current MetLife Inc (MET) share price?
- MetLife Inc last traded at $84.63 with a market capitalisation of about $54.5B.
- What is the analyst price target for MET?
- The mean analyst price target for MetLife Inc is $92.25, roughly 9.0% above the latest price. The current consensus rating is “Buy”.
- Where can I see MetLife Inc's full financial metrics?
- Luminoso tracks MET's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.